Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia. Lu P, Zhang X, Yang J, Li J, et al. Blood 2024 Nov 19:blood.2024024861. doi: 10.1182/blood.2024024861.

Read + Share

Amedeo Smart

Independent Medical Education

Lu P, Zhang X, Yang J, Li J, et al. Nanobody-based Naturally Selected CD7-Targeted CAR-T Therapy for Acute Myeloid Leukemia. Blood 2024 Nov 19:blood.2024024861. doi: 10.1182/blood.2024024861.
PMID: 39561281